• Subscribe
  • Advertise
  • About us
  • Follow
  • Follow
  • Follow
  • Follow
Pharmafile Logo
  • Magazine
    • PharmaTimes Magazine Archive
  • Web Exclusives
  • News
  • Competitions
  • Appointments
  • Business Insights
  • Webinars
  • Thought Leadership

GSK to file shingles jab this year

by Selina McKee | 16th Sep 2016 | News

Tags


Related posts

Transgene completes randomisation in phase 2 trial of tg4050

Transgene completes randomisation in phase 2 trial of tg4050

Apr 13, 2026

Bayer wins MHRA approval for Kerendia in heart failure

Bayer wins MHRA approval for Kerendia in heart failure

Apr 13, 2026

Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb

Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb

Apr 9, 2026

Kainova expands DT 7012 trial into Europe

Kainova expands DT 7012 trial into Europe

Apr 9, 2026

News alerts

This field is required.

Latest content

  • Transgene completes randomisation in phase 2 trial of tg4050
  • Bayer wins MHRA approval for Kerendia in heart failure
  • Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
  • Kainova expands DT 7012 trial into Europe
  • Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease

Contact details

PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN

E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999

Get the latest pharma news delivered to your inbox

A valid email address is required.

Download our apps

Go to the App Store or Google Play and search for ‘PharmaTimes’ to download our free app.

Content

News
Magazine
Advertise
Contact
Competitions

Connect

  • Follow
  • Follow
  • Follow
  • Follow
  • Follow

Legal

Privacy Policy
Terms and Conditions
Editorial policy
Cookies
RSS – feed subscriptions
© Copyright PharmaTimes Media Limited 2026